EVALUATION OF THE QUALITY OF DICLOFENAC SODIUM COATED TABLETS PROVIDED BY THE SÃO PAULO PUBLIC HEALTH SYSTEM, SP, BRAZIL

Authors

  • Jaqueline Kalleian Eserian Centro de Medicamentos, Cosméticos e Saneantes, Instituto Adolfo Lutz Avenida Doutor Arnaldo, 355, Prédio BQ, 5º andar, Cerqueira César, São Paulo, SP, CEP 01246-902
  • Márcia Lombardo Centro de Medicamentos, Cosméticos e Saneantes, Instituto Adolfo Lutz Avenida Doutor Arnaldo, 355, Prédio BQ, 5º andar, Cerqueira César, São Paulo, SP, CEP 01246-902

DOI:

https://doi.org/10.14450/2318-9312.v28.e3.a2016.pp185-190

Keywords:

diclofenac, enteric-coated tablets, drug liberation, public health, drug monitoring

Abstract

Diclofenac is the most prescribed nonsteroidal anti-inflammatory (NSAI) drug in the world. Diclofenac sodium gastro- resistant tablets were developed for reducing the risk of gastrointestinal adverse effects, commonly associated to
NSAI. The Municipal Drug Quality Verification Program of São Paulo, SP, Brazil, evaluates the quality of diclofenac sodium coated tablets distributed by the municipal Public Health System. Therefore, the objective of this study was
to evaluate the quality of diclofenac sodium coated tablets distributed in municipal public health units in the year of 2013. The Pharmacopoeal physical-chemical tests performed included aspect, weight variation, diclofenac sodium
identification and potency, uniformity of dosage units and dissolution. The analyzed diclofenac sodium samples presented satisfactory results. Monitoring drugs distributed by the Public Health System is an important health surveillance action. The evaluation of diclofenac sodium coated tablets quality is relevant to guarantee the efficacy and safety of the pharmacological treatment, especially because it is a modified release pharmaceutical product.

Downloads

Published

2016-09-30

How to Cite

Eserian, J. K., & Lombardo, M. (2016). EVALUATION OF THE QUALITY OF DICLOFENAC SODIUM COATED TABLETS PROVIDED BY THE SÃO PAULO PUBLIC HEALTH SYSTEM, SP, BRAZIL. Infarma - Pharmaceutical Sciences, 28(3), 185–190. https://doi.org/10.14450/2318-9312.v28.e3.a2016.pp185-190

Issue

Vol. 28 No. 3 (2016)

Section

Technical Note

License

Authors who publish in this journal agree to the following terms:

 

  1. Authors retain the copyright and grant the journal the right of first publication, with the work simultaneously licensed under the Licença Creative Commons Attribution which allows the sharing of work with acknowledgment of authorship and initial publication in this journal.
  2. Authors are authorized to take additional contracts separately, for non-exclusive distribution of the version of the work published in this journal (e.g. publish in institutional repository or as a book chapter), with acknowledgment of authorship and initial publication in this journal.
  3. Authors are allowed and encouraged to publish and distribute their work online (e.g. in institutional repositories or on their personal page) at any point before or during the editorial process, as this can generate productive changes as well as increase the impact and Citation of published work (See O Efeito do Acesso Livre ).